A detailed history of Paladin Advisory Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Paladin Advisory Group, LLC holds 1,806 shares of ABT stock, worth $204,944. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,806
Previous 1,920 5.94%
Holding current value
$204,944
Previous $199,000 3.02%
% of portfolio
0.15%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$100.07 - $118.13 $11,407 - $13,466
-114 Reduced 5.94%
1,806 $205,000
Q4 2023

Jan 31, 2024

SELL
$90.19 - $110.4 $11,454 - $14,020
-127 Reduced 6.2%
1,920 $211,000
Q1 2023

Apr 21, 2023

BUY
$96.86 - $114.01 $198,272 - $233,378
2,047 New
2,047 $207,000
Q1 2022

Apr 15, 2022

BUY
$114.02 - $139.04 $233,398 - $284,614
2,047 New
2,047 $242,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Paladin Advisory Group, LLC Portfolio

Follow Paladin Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paladin Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paladin Advisory Group, LLC with notifications on news.